COVID-19 Vaccine: Zydus Cadila, Bharat Biotech in Phase II trial
New Delhi: Indian Council of Medical Research (ICMR) Director General Balaram Bhargava said on Tuesday that Bharat Biotech and Zydus Cadilla are doing human trials of the second phase of the Corona vaccine while Serum Institute of India is about to start the third phase of testing soon.
Speaking at a press conference organised by the Union Ministry of Health and Family, Dr Bhargava said at present there are three Corona vaccines in various stages of clinical trials. He said Phase I human trials of Cadila's Corona vaccine has been completed and volunteers have been selected for Phase II testing.
There are three doses of this vaccine which are to be taken at intervals of 28–28 days.
The first phase of Bharat Biotech has also been completed and the results are being reviewed. Bharat Biotech has also selected the volunteers for the Phase II trial.
The Serum Institute tested on 100 volunteers for a second phase test for the Corona vaccine and then took a seven-day break as they wanted to begin the third phase. The Serum Institute intends to conduct a Phase III trial on 1,500 patients at 14 sites across the country.
Next Story
